Risks of anticholinergic drugs

Adverse effects of drugs among the elderly should be given special attention when considering a pharmacological intervention.

Two recent papers using large electronic health records have explored the impact of drugs with anticholinergic properties.

The first, “Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease” view here used a HealthFacts database (Cerner Corporation, Kansas City, Missouri, USA) composed of 16,302 patients with Parkinson disease.

The second “Anticholinergic drugs and risk of dementia: case-control study” view here utilized 14,453 patients with dementia and 86,403 controls from the UK Clinical Practice Research Datalink.

Both studies observed a robust relationship between the use of drugs with anticholinergic properties and adverse consequences, including dementia, increased risks of visit to emergency departments and risk of fracture.  Both studies demonstrate the importance of large electronic health record systems in understanding adverse drug events.

Posted in

More RSI News

RSI wins 2019 Consulting Engineers of Ontario Award of Merit

June 14, 2019
RSI logo in white

Risk Sciences International (RSI), as members of a consulting team with Stantec, along with the Ontario First Nations Technical Services Corporation (OFNTSC), has won an Award of Merit from the…

Read News Item

Updated CSA Technical Guide for Infrastructure in Permafrost published

June 4, 2019
RSI logo in white

A second updated edition of the CSA national permafrost standard was published on May 21, 2019 and features climate and climate change information provided by…

Read News Item

RSI chairs panel session at Building the Next Generation of Canadian Infrastructure Conference

May 15, 2019
RSI logo in white

RSI chairs and presents on panel sessions for the Toronto conference, “Building the Next Generation of Canadian Infrastructure: Defining a roadmap for optimizing infrastructure planning,…

Read News Item

RSI Chairs Joint FAO/WHO Expert Meeting on Microbiological Risk Assessment (JEMRA)

March 28, 2019
RSI logo in white

RSI’s Dr. Emma Hartnett chaired the recent Joint FAO/WHO Expert Meeting on Microbiological Risk Assessment (JEMRA). The focus of the week-long event held March 11…

Read News Item